preloader icon



Apex Trader Funding - News

RaySearch Laboratories: Interim report April - June 2024

STOCKHOLM, Aug. 16, 2024 /PRNewswire/ --  SECOND QUARTER (APRIL- JUNE 2024)       Order intake SEK 290.3 M (239.2) Net sales SEK 318.9 M (239.5) Operating profit SEK 79.3 M (18.2) Profit after tax SEK 61.4 M (10.9) Earnings per share before/after dilution SEK 1.79 (0.32) Cash flow from operating activities SEK 154.6 M (67.2) Order backlog SEK 1,790.5 M (1,954.9) at the end of the period HALF-YEAR (JANUARY- JUNE 2024) Order intake SEK 528.8 M (445.8) Net sales SEK 576.1 M (469.6) Operating profit SEK 125.1 M (41.9) Profit after tax SEK 98.1 M (28.5) Earnings per share before/after dilution SEK 2.86 (0.83) Cash flow from operating activities SEK 321.9 M (220.9) SIGNIFICANT EVENTS DURING THE SECOND QUARTER